Author

Fanny Leenhardt

IRCM, Univ Montpellier, ICM, INSERM, Montpellier, France;ORCID 0000-0002-9404-5044Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abdelhay BoulahtoufiD· 1 shared Alexandre Evrard· 1 shared Alice MatheuxiD· 1 shared Amélie Gudin-de-ValleriniD· 1 shared Céline GongoraiD· 1 shared Eric Fabbrizio· 1 shared Florence BoissièreiD· 1 shared Julia Toucheboeuf· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdelhay BoulahtoufORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Pregnane X Receptor (PXR) contributes to phenotypic plasticity and modulates the sensitivity to targeted therapies in melanoma

Stefan D Nicolescu, Alice Matheux, Marina Grimaldi, Nadia Vie, Raphaël Romero, Mathilde Robin, Eric Fabbrizio, Abdelhay Boulahtouf, Julia Toucheboeuf, Amélie Gudin-de-Vallerin, Florence Boissière, Fanny Leenhardt, Litaty Mbatchi, Laura Tallevast, Patrick Balaguer, , Philippe Pourquier

This study shows that PXR expression in melanoma cells increases sensitivity to BRAFi/MEKi treatment and is linked to a melanocytic phenotype.

bioRxiv · Nov 4, 2026 · PreprintCancer Biology